1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ASTHMA AND COPD DRUGS MARKET, BY DRUG CLASS (USD BILLION)
6.1. Bronchodilators
6.2. Corticosteroids
6.3. Combination Drugs
6.4. Leukotriene Modifiers
7. ASTHMA AND COPD DRUGS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Inhalation
7.2. Oral
7.3. Injection
7.4. Nasal
8. ASTHMA AND COPD DRUGS MARKET, BY APPLICATION (USD BILLION)
8.1. Asthma
8.2. Chronic Obstructive Pulmonary Disease
8.3. Allergic Rhinitis
8.4. Pulmonary Hypertension
9. ASTHMA AND COPD DRUGS MARKET, BY PATIENT GROUP (USD BILLION)
9.1. Adult
9.2. Pediatric
9.3. Geriatric
10. ASTHMA AND COPD DRUGS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Asthma and COPD Drugs Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Asthma and COPD Drugs Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Merck and Co
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Pfizer
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Sandoz
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Amgen
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Roche
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Boehringer Ingelheim
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Johnson and Johnson
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Teva Pharmaceutical Industries
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Novartis
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Mylan
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. AstraZeneca
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. GlaxoSmithKline
<
pan style="font-family: arial, helvetica, sans-serif;">12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Chiesi Farmaceutici
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Eli Lilly and Company
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Sanofi
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 8. US ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 9. US ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 10. US ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 11. US ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 28. UK ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 29. UK ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 30. UK ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 31. UK ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 58. APAC ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 59. APAC ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 60. APAC ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 61. APAC ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT GROUP, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN ASTHMA AND COPD DRUGS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
